Clinical Trial Update: Endoscopic Injection Sclerotherapy Versus N-butyl-2-cyanoacrylate Injection [Phase 3]

View source ↗

Summary

This Phase 3 trial compares endoscopic injection sclerotherapy with N-butyl-2-cyanoacrylate injection for treating bleeding esophageal varices; the study status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Variceal Bleeding

Drugs mentioned

• Endoscopic injection sclerosant (unspecified) (sclerosant used in endoscopic injection sclerotherapy)
• N-butyl-2-cyanoacrylate (cyanoacrylate tissue adhesive)

Snippet

Sponsor: Sherief Abd-Elsalam | Conditions: Bleeding Esophageal Varices | Phase 3 | Status: UNKNOWN